Login / Signup

Poly(2-ethyl-2-oxazoline)-IR780 conjugate nanoparticles for breast cancer phototherapy.

Cátia G AlvesRita Lima-SousaBruna L MeloPaula C N FerreiraAndré Ferreira MoreiraIlídio Joaquim CorreiaDuarte de Melo-Diogo
Published in: Nanomedicine (London, England) (2023)
Aims: To address the limitations of IR780 by preparing hydrophilic polymer-IR780 conjugates and to employ these conjugates in the assembly of nanoparticles (NPs) intended for cancer photothermal therapy. Materials & methods: The cyclohexenyl ring of IR780 was conjugated for the first time with thiol-terminated poly(2-ethyl-2-oxazoline) (PEtOx). This novel poly(2-ethyl-2-oxazoline)-IR780 (PEtOx-IR) conjugate was combined with D-α-tocopheryl succinate (TOS), leading to the assembly of mixed NPs (PEtOx-IR/TOS NPs). Results: PEtOx-IR/TOS NPs displayed optimal colloidal stability as well as cytocompatibility in healthy cells at doses within the therapeutic range. In turn, the combination of PEtOx-IR/TOS NPs and near-infrared light reduced heterotypic breast cancer spheroid viability to just 15%. Conclusion: PEtOx-IR/TOS NPs are promising agents for breast cancer photothermal therapy.
Keyphrases
  • squamous cell carcinoma
  • cancer therapy
  • ionic liquid
  • induced apoptosis
  • mass spectrometry
  • young adults
  • high resolution
  • fluorescent probe
  • liquid chromatography
  • pi k akt